Loading
Latest filing published 15 Sept 2026 for Ange Prostatype Genomics AB, €5,513. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Anders Koch is a declared insider of Ange Prostatype Genomics AB, with filings sourced from Finansinspektionen. Altogether 2 filings, all relating to 15 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 15 September 2026 came the latest disclosure, a transaction for €5,513 in Ange Prostatype Genomics AB. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations